Polymyxin B, used to treat infections caused by antibiotic-resistant Gram-negative bacteria, produces nephrotoxicity at its current dosage. We show that a combination of nonbactericidal concentration of this drug and lysophosphatidylcholine (LPC) potently inhibits growth of Salmonella and at least two other Gram-negative bacteria in vitro This combination makes bacterial membrane porous and causes degradation of DnaK, the regulator of protein folding. Polymyxin B-LPC combination may be an effective and safer regimen against drug-resistant bacteria. Copyright © 2020 American Society for Microbiology.
Jitender Yadav, Sana Ismaeel, Ayub Qadri. Lysophosphatidylcholine Potentiates Antibacterial Activity of Polymyxin B. Antimicrobial agents and chemotherapy. 2020 Nov 17;64(12)
PMID: 32988824
View Full Text